Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.

Withdrawn before enrolling · Not applicable

Conditions studied: Vulvar Cancer

In brief

The purpose of this study is to determine if regular and daily repeated application of the ciclopirox lotion to vulva will make the precancerous lesion(s) shrink or even disappear.

Key facts

Study ID

NCT00382330

Run by

University of Medicine and Dentistry of New Jersey

People needed

0

Last updated by the study team

2013-09-06

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients between the ages 18 and 75 years.
• Patients may be carriers of the Human Immunodeficiency Virus (HIV).
• Patients must have been diagnosed with precancerous lesion(s) of the vulva by tissue sampling (biopsy-proven vulvar intraepithelial neoplasia grade II or III)
• Patients must be able to come to University Hospital for their initial appointment in Gynecologic Oncology Clinic, and for the eight follow-up visits in that Clinic required by the protocol.

You may not qualify if…

• Pregnant or patients who are breast feeding a baby.
• Patients who have been diagnosed with a vaginal yeast infection.
• Patients who have undergone prior surgery for precancerous lesion(s) of the vulva.

Where it is running

• University of Medicine and Dentistry of NJ — Newark, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.